Citizens Business Bank’s Edwards Lifesciences EW Stock Holding History

Citizens Business Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.48M	Sell	30,969 -55	-0.2%	-$4.53K	0.41%	62
2025 Q4	$2.64M	Buy	31,024 +548	+2%	+$45K	0.44%	58
2025 Q3	$2.37M	Buy	30,476 +518	+2%	+$40.5K	0.4%	58
2025 Q2	$2.34M	Buy	29,958 +1,354	+5%	+$101K	0.46%	60
2025 Q1	$2.07M	Buy	28,604 +5,454	+24%	+$390K	0.45%	60
2024 Q4	$1.9M	Sell	23,150 -10,039	-30%	-$703K	0.36%	61
2024 Q3	$2.19M	Sell	33,189 -885	-3%	-$64.3K	0.44%	63
2024 Q2	$3.15M	Sell	34,074 -201	-0.6%	-$17.8K	0.67%	49
2024 Q1	$3.28M	Buy	+34,275	New	+$2.88M	0.68%	47

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Citizens Business Bank's EW Position: Q1 2026 in Review

Citizens Business Bank reduced its Edwards Lifesciences (EW) stake by 0.18% in Q1 2026, selling an estimated $4.53K and leaving 30,969 shares worth $2.48M. The position accounts for 0.41% of the portfolio, ranked #62.

Citizens Business Bank first reported a position in EW in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.28M in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Citizens Business Bank held 30,969 shares of Edwards Lifesciences worth $2.48M as of Q1 2026.
Citizens Business Bank sold 55 Edwards Lifesciences shares in Q1 2026, an estimated $4.53K.
Edwards Lifesciences made up 0.41% of Citizens Business Bank's portfolio in Q1 2026, its #62 holding.
Citizens Business Bank first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 9 quarters since.
Citizens Business Bank's Edwards Lifesciences position peaked at $3.28M in Q1 2024.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Citizens Business Bank's 13F filing for Q1 2026, filed 1 May 2026.